BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Park MD, Reyes-Torres I, LeBerichel J, et al. (2023) TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer. Nature Immunology |
Grout JA, Sirven P, Leader AM, et al. (2022) Spatial positioning and matrix programs of cancer-associated fibroblasts promote T cell exclusion in human lung tumors. Cancer Discovery |
Leader AM, Grout JA, Maier BB, et al. (2021) Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification. Cancer Cell |
Casanova-Acebes M, Dalla E, Leader AM, et al. (2021) Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells. Nature |
Hegde S, Leader AM, Merad M. (2021) MDSC: Markers, development, states, and unaddressed complexity. Immunity. 54: 875-884 |
Oh SA, Wu DC, Cheung J, et al. (2020) PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer. Nature Cancer. 1: 681-691 |
Brown BD, Leader AM, Vilcek J, et al. (2020) "America First" Will Destroy U.S. Science. Cell |
Maier B, Leader AM, Chen ST, et al. (2020) Author Correction: A conserved dendritic-cell regulatory program limits antitumour immunity. Nature |
Maier B, Leader AM, Chen ST, et al. (2020) A conserved dendritic-cell regulatory program limits antitumour immunity. Nature. 580: 257-262 |
Oh SA, Wu D, Cheung J, et al. (2020) PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer Nature Cancer. 1: 681-691 |